US 8846638
Macrocyclic nucleoside phosphoramidate derivatives
granted A61KA61K31/7064A61K31/7076
Quick answer
US patent 8846638 (Macrocyclic nucleoside phosphoramidate derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/7064, A61K31/7076, A61K45/06